StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Last viewed:
abus
Prices are updated after-hours
Sector
Health Technology
1
Industry
Biotechnology
1
Name
Arbutus Biopharma Corporation
1
Symbol
Abcb
1
Abcm
1
Abnb
1
Abus
1
Acad
1
Acgl
1
Aciu
1
Acls
1
Adil
1
Adpt
1
Adtn
1
Adtx
1
Adus
1
Adxs
1
Aeis
1
Aey
1
Aeye
1
Agen
1
Agys
1
Ahpi
1
Akam
1
Algt
1
Alny
1
Altr
1
Amcx
1
Amd
1
Amsc
1
Amsf
1
Amtx
1
Apei
1
Apen
1
Aplt
1
Arko
1
Asle
1
Asmb
1
Asps
1
Aspu
1
Atcx
1
Atec
1
Atex
1
Athe
1
Atif
1
Atnf
1
Atrc
1
Avav
1
Awre
1
Axgn
1
Axon
1
Axti
1
Ayla
1
Ayro
1
Azn
1
Banf
1
Banr
1
Batra
1
Bbcp
1
Bbi
1
Bbig
1
Bbio
1
Bcel
1
Tags
Hepatitis
1
Injection
1
Venue
Nasdaq
1
Ipo Year
N::a
1
Country
United States
1
Sec Forms
10-k
1
10-k::a
1
10-q
1
3
1
4
1
424b5
1
8-k
1
Corresp
1
Ct Order
1
Def 14a
1
Defa14a
1
Effect
1
S-3
1
S-8
1
Sc 13g
1
Sc 13g::a
1
Upload
1
Sec Forms Date
2021 - 08 - 05
1
2021 - 07 - 14
1
2021 - 07 - 07
1
2021 - 07 - 06
1
2021 - 06 - 29
1
2021 - 06 - 28
1
2021 - 06 - 07
1
2021 - 06 - 01
1
2021 - 05 - 05
1
2021 - 04 - 08
1
2021 - 04 - 01
1
2021 - 03 - 16
1
2021 - 03 - 04
1
2021 - 02 - 26
1
2021 - 02 - 17
1
2021 - 02 - 16
1
2021 - 02 - 12
1
2021 - 02 - 10
1
2021 - 02 - 01
1
2021 - 01 - 25
1
2020 - 12 - 16
1
2020 - 12 - 10
1
2020 - 11 - 16
1
2020 - 11 - 05
1
2020 - 10 - 22
1
2020 - 10 - 21
1
2020 - 09 - 25
1
2020 - 09 - 15
1
2020 - 09 - 03
1
2020 - 09 - 01
1
2020 - 08 - 28
1
2020 - 08 - 27
1
2020 - 08 - 10
1
2020 - 08 - 07
1
2020 - 07 - 27
1
2020 - 07 - 24
1
2020 - 07 - 23
1
2020 - 07 - 16
1
2020 - 06 - 24
1
2020 - 06 - 01
1
2020 - 05 - 18
1
2020 - 05 - 11
1
2020 - 04 - 24
1
2020 - 03 - 26
1
2020 - 03 - 06
1
2020 - 03 - 05
1
2020 - 02 - 19
1
2020 - 02 - 14
1
2020 - 02 - 10
1
2020 - 01 - 13
1
2020 - 01 - 10
1
2020 - 01 - 08
1
2019 - 12 - 27
1
2019 - 12 - 23
1
2019 - 12 - 09
1
2019 - 11 - 06
1
2019 - 11 - 05
1
2019 - 10 - 03
1
2019 - 08 - 26
1
2019 - 08 - 20
1
News In 15d
1
1
News In 30d
2
1
Created At
2020 - 11 - 27
1
Abus
Nasdaq
2021 - 02 - 26
Arbutus Biopharma Corporation
ABUS
|
$2.74
-0.36%
-0.36%
340K
|
Health Technology
(
0.0%
1d)
(
10.4%
1m)
(
8.7%
1y)
(
0.0%
2d)
(
0.0%
3d)
(
1.1%
7d)
(
-68.05%
volume)
Earnings Calendar: 2024-02-29
Market Cap: $ 491,808,625
http://www.arbutusbio.com
Sec Filling
|
Patents
| 80 employees
ABUS
(US) Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.
hepatitis
injection
add to watch list
Paper trade
email alert is off
Press-releases
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
Published:
2024-04-18
(Crawled : 12:00)
- globenewswire.com
ABUS
|
$2.74
-0.36%
-0.36%
340K
|
Health Technology
|
-5.82%
|
O:
-5.82%
H:
0.0%
C:
0.0%
first
report
update
financial
results
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
Published:
2024-04-04
(Crawled : 12:30)
- globenewswire.com
MRNA
|
News
S
|
$108.82
0.86%
0.85%
3.4M
|
Health Technology
|
7.55%
|
O:
1.46%
H:
3.2%
C:
-0.41%
ABUS
|
$2.74
-0.36%
-0.36%
340K
|
Health Technology
|
9.56%
|
O:
16.73%
H:
6.14%
C:
2.39%
patent
construction
biopharma
ongoing
Barinthus Bio Reports Full Year 2023 Financial Results and Update on Corporate Developments
Published:
2024-03-20
(Crawled : 12:00)
- globenewswire.com
ABUS
|
$2.74
-0.36%
-0.36%
340K
|
Health Technology
|
8.7%
|
O:
-1.58%
H:
3.05%
C:
2.41%
year
update
financial
results
Lipid-Nanoparticle Based Genomic Medicines Market worth $32.5 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
Published:
2024-03-18
(Crawled : 14:00)
- prnewswire.com
CVAC
|
$2.51
-3.46%
-3.59%
1.1M
|
Health Technology
|
-23.94%
|
O:
0.0%
H:
0.0%
C:
-2.73%
BNTX
|
News
|
$88.18
-0.35%
-0.35%
280K
|
Health Technology
|
-4.75%
|
O:
0.48%
H:
1.18%
C:
0.08%
ABUS
|
$2.74
-0.36%
-0.36%
340K
|
Health Technology
|
4.96%
|
O:
0.38%
H:
0.38%
C:
-3.42%
report
genomic
market
Arbutus to Participate in Two Upcoming Investor Conferences
Published:
2024-03-08
(Crawled : 12:30)
- globenewswire.com
ABUS
|
$2.74
-0.36%
-0.36%
340K
|
Health Technology
|
0.0%
|
O:
0.18%
H:
0.0%
C:
0.0%
Arbutus to Participate in Two Upcoming Investor Conferences - March 8, 2024
Published:
2024-03-08
(Crawled : 14:30)
- biospace.com/
ABUS
|
$2.74
-0.36%
-0.36%
340K
|
Health Technology
|
0.0%
|
O:
0.18%
H:
0.0%
C:
0.0%
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
Published:
2024-02-29
(Crawled : 12:30)
- globenewswire.com
ROIV
|
$10.89
-0.46%
-0.46%
2.8M
|
Manufacturing
|
-6.92%
|
O:
1.2%
H:
0.34%
C:
-3.46%
ABUS
|
$2.74
-0.36%
-0.36%
340K
|
Health Technology
|
-5.5%
|
O:
-1.37%
H:
0.0%
C:
-2.44%
year
update
financial
results
Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update
Published:
2024-02-15
(Crawled : 12:30)
- globenewswire.com
ABUS
|
$2.74
-0.36%
-0.36%
340K
|
Health Technology
|
-5.98%
|
O:
0.85%
H:
0.0%
C:
-1.36%
report
year
update
financial
results
Arbutus Announces 2024 Corporate Objectives and Provides Financial Update
Published:
2024-01-08
(Crawled : 13:00)
- globenewswire.com
ABUS
|
$2.74
-0.36%
-0.36%
340K
|
Health Technology
|
14.11%
|
O:
3.32%
H:
3.21%
C:
-1.61%
update
financial
Barinthus Bio Presents Interim Data from Phase 2b HBV003 Trial and Phase 2a AB-729-202 Trial in Collaboration with Arbutus Biopharma in Chronic HBV Patients at AASLD
Published:
2023-11-09
(Crawled : 21:00)
- globenewswire.com
ABUS
|
$2.74
-0.36%
-0.36%
340K
|
Health Technology
|
52.78%
|
O:
1.67%
H:
0.0%
C:
-3.28%
hbv003
biopharma
collaboration
trial
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0001447028-24-000029
4
2024-02-06
2024-02-01
Buy
A
380500
380500
0001447028-24-000029
4
2024-02-06
2024-02-01
Buy
A
95100
95100
0001447028-24-000028
4
2024-02-06
2024-02-01
Buy
A
403900
403900
0001447028-24-000028
4
2024-02-06
2024-02-02
Sell
S
4358
125542
0001447028-24-000028
4
2024-02-06
2024-02-01
Buy
A
101000
129900
Your Today's Watch List
Sign in to create a watchlist
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Last 48 Hours Insiders Buying
RKT
P
347
|
$12.55
-0.63%
0.48%
1.7M
|
Finance
|
22:30
NWFL
|
News
|
$24.6
2.03%
1.99%
9.9K
|
Finance
|
22:00
TGEN
P
10000
|
$0.685
39.71%
6.6K
|
Utilities
|
20:01
MNSB
P
310
|
$15.88
-2.93%
-3.02%
46K
|
Finance
|
15:30
RMCF
|
$3.54
0.28%
7.1K
|
Consumer Non-Durables
|
20:10
12 months watchlist earnings calendar